Dr. Mitwally is internationally recognized for his groundbreaking work in fertility treatments, particularly his pioneering use of aromatase inhibitors such as Letrozole for ovulation induction.
His innovative approach has led to multiple patents and has transformed fertility treatment protocols worldwide, offering new hope to patients with challenging fertility issues.
Dr. Mitwally's inventions have helped thousands of couples achieve pregnancy, often at lower cost and with fewer side effects than traditional treatments.
Dr. Mitwally's most significant contribution to fertility treatment is his pioneering work with Letrozole, an aromatase inhibitor originally developed for breast cancer treatment.
His research demonstrated that Letrozole could be repurposed as a highly effective fertility treatment, offering advantages over traditional medications like Clomiphene citrate, including:
US Patent 10,231,970 • Issued March 19, 2019
This patent covers the use of aromatase inhibitors such as Letrozole for treating infertility in postpartum patients, offering a novel approach for women experiencing difficulty conceiving after childbirth.
View Patent DocumentUS Patent 8,058,262 • Issued November 15, 2011
This groundbreaking patent established the use of aromatase inhibitors, particularly Letrozole, as a treatment for infertility in humans. This innovation has transformed fertility treatment protocols worldwide.
View Patent DocumentUS Patent 7,700,590 • Issued April 20, 2010
This patent covers the use of aromatase inhibitors for treating various benign gynecological disorders, expanding the application of these compounds beyond fertility treatments.
View Patent DocumentUS Patent Application 20050209261 • Issued September 22, 2005
This patent application describes methods for using aromatase inhibitors to enhance ovarian response to gonadotropin stimulation, improving outcomes in assisted reproductive technologies.
View Patent DocumentUS Patent Application • Issued 2006
This patent covers innovative methods for treating ectopic pregnancies using aromatase inhibitors, providing a potentially less invasive alternative to surgical intervention in certain cases.
View Patent DocumentUS Patent Application • Issued 2006
This patent application details the use of aromatase inhibitors as emergency contraception, offering a potential alternative to traditional emergency contraceptive methods.
View Patent DocumentUS Patent Application • Issued 2007
This patent describes protocols for endometrial thinning using aromatase inhibitors, which can be beneficial in various gynecological procedures and treatments.
View Patent DocumentDr. Mitwally's innovations have helped over a million patients worldwide achieve pregnancy.
Letrozole is now used as a fertility treatment in more than 40 countries around the world.
Treatment with Letrozole typically costs about 30% less than traditional fertility medications.
"Dr. Mitwally's pioneering work with Letrozole has revolutionized fertility treatment, offering new hope to patients who previously had limited options. His contributions to reproductive medicine will benefit generations to come."
Office Hours:
Monday-Friday: 8:00 am - 5:00 pm
Saturday: 8:00 am - 12:00 pm
By Appointment only.
Call or Text: (432) 580-4500
Fax: (210) 265-5665
Email: sarafertility@gmail.com
Ohio Address:
109B Commerce Park Dr.
Westerville, OH 43082